ICON Plc

ICON Plc ICON is a global provider of outsourced clinical research development services to the pharmaceutical, biotechnology, and medical device industries.

We help our clients accelerate the development of life-saving drugs that improve patients' quality of life.

Celebrating excellence at the 2025 MarCom Awards!Our Creative & Digital Services, Global Medical Communications, and Pat...
15/12/2025

Celebrating excellence at the 2025 MarCom Awards!

Our Creative & Digital Services, Global Medical Communications, and Patient Recruitment .

Solutions teams have earned five MarCom honours this year:
- Platinum: ISMPP Academy Poster
- Gold: Graphic Poster Template for Medical Congresses (Pfizer)
- Gold: 812P401 Study Materials (Supernus)
- Gold: LUCERNA Study Materials (Astellas)
- Honourable Mention: “Getting Help During Active Pain Crises in Sickle Cell Disease” Manuscript Plain Language Summary (Pfizer)

Congratulations to the teams for setting the standard in creativity and strategic communications.

In a fast-moving market like healthcare, speed matters. Metys®, from Symphony Health, an ICON plc company, delivers week...
15/12/2025

In a fast-moving market like healthcare, speed matters.

Metys®, from Symphony Health, an ICON plc company, delivers weekly insights up to 3 days faster than other platforms – so you can respond to competitive shifts with confidence and clarity.
Stay ahead. Stay informed.

Explore Metys: https://ow.ly/YrZX50XjB57

AI and predictive analytics are transforming clinical data risk management. CRAs are essential to successful trial. Read...
12/12/2025

AI and predictive analytics are transforming clinical data risk management. CRAs are essential to successful trial.

Read more on how tech empowers, not replaces, the CRA. Read the ACT article: https://ow.ly/ESvn50XB6TW

Latest issue out now. Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousan...
12/12/2025

Latest issue out now.
Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered the convenience of this free monthly publication by signing up today: https://ow.ly/Uv0m50Xz2bq

Compiled and collated by ICON’s Regulatory Intelligence Team and delivered monthly to your inbox, it provides the overview you need, with convenient links to the detailed sources.

Stay ahead of the dynamic and ever-changing world of clinical trial regulations by signing up today!

Innovation is accelerating progress in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions bring t...
11/12/2025

Innovation is accelerating progress in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions bring together advanced formulation design, real-time dose flexibility, and world-class CMC expertise to simplify complexity and speed timelines. This article discusses how the integration of science, technology and strategic insight can transform challenges into opportunities for breakthrough success. https://ow.ly/xiUY50XHgNA

ICON is proud to be recognised among the top global companies in the world for female employees. This recognition is bas...
11/12/2025

ICON is proud to be recognised among the top global companies in the world for female employees. This recognition is based on a comprehensive survey of approximately 120,000 women across more than 36 countries, highlighting organisations that excel in promoting gender equality and empowering women in the workplace. We’re honoured to be part of this distinguished group.

As of 31 December 2024, women make up 70% of our workforce and hold 60% of director-level and above roles—a powerful reflection of the inclusive environment at ICON. Learn more in our latest report https://ow.ly/oemc50Xfnbt

With PubsHub Journals & Congresses, you’ll receive real-time alerts for updates, extensions, and changes to deadlines on...
11/12/2025

With PubsHub Journals & Congresses, you’ll receive real-time alerts for updates, extensions, and changes to deadlines on your personalized watch list. That means fewer surprises - and better decisions. See how easy it is to stay informed and in control. Request a demo today. https://ow.ly/exjF50XaS2Q

Data is the foundation of every decision in clinical development, yet the journey from first patient interaction to fina...
11/12/2025

Data is the foundation of every decision in clinical development, yet the journey from first patient interaction to final submission is rarely seen in full.

Our latest blog takes you behind the scenes to explore how information is collected, verified, and transformed into insights that support regulatory decisions and patient outcomes.

Read more: https://ow.ly/RuUb50XFK52

Traditional trial settings often fail to reveal the added value of emerging HIV therapies. Explore how developers can pl...
11/12/2025

Traditional trial settings often fail to reveal the added value of emerging HIV therapies. Explore how developers can plan trials that demonstrate the true advantages and utility of an HIV intervention in the article from ICON. https://ow.ly/MmhG50XAB5O

What should you consider when choosing a training dataset for your AI-enabled SaMD? Our whitepaper has the answers. Lear...
11/12/2025

What should you consider when choosing a training dataset for your AI-enabled SaMD? Our whitepaper has the answers. Learn about AI models and data best practices and plan for your FDA Pre-Sub. Download it today. https://ow.ly/nI8g50XAzbq

CRAs are at the centre of clinical trial evolution. Risk-based monitoring, intelligent oversight tools and AI are changi...
10/12/2025

CRAs are at the centre of clinical trial evolution. Risk-based monitoring, intelligent oversight tools and AI are changing how trials are managed. ICON explores what this means for the future in Pharma Times: https://ow.ly/FS6950XGlPC

Address

South County Business Park, Leopardstown
Dublin
18

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+35312912000

Alerts

Be the first to know and let us send you an email when ICON Plc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ICON Plc:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram